ESC 365 - Targeting lipids: lessons learned with novel therapeutics and horizons ahead

ESC Professional Premium Access

Targeting lipids: lessons learned with novel therapeutics and horizons ahead

Session: Practice-changing studies from NEJM 2024

Topic: Risk Factors and Prevention

Speaker: Professor J. Kastelein (Amsterdam, NL)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor John Kastelein

Antoni van Leeuwenhoek Hospital (AVL), Amsterdam (Netherlands (The))

36 presentations

6 followers

3 more presentations in this session

Coronary stents and transcatheter therapies for structural heart disease: what have we learned in 2024?

Speaker: Assistant Professor B. Stahli (Zurich, CH)

Getting to the heart of the matter: GLP1 receptor agonists and cardiovascular disease

Speaker: Professor D. McGuire (Dallas, US)

Moving beyond diuretics: advances in treatment of cardiomyopathies and heart failure

Speaker: Professor T. McDonagh (London, GB)

Access the full session

Practice-changing studies from NEJM 2024

Speakers: Professor J. Kastelein, Assistant Professor B. Stahli, Professor D. McGuire, Professor T. McDonagh

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources